Principal Investigator Dr Mark Kotter and Co-Principal Investigator Dr Ben Davies are excited to announce the launch of the first regenerative medicine trial for Degenerative Cervical Myelopathy (DCM) at Cambridge University Hospitals. RECEDE-Myelopathy is a phase 3, double blind, randomised…
Welcome to the RECODE-DCM Network! Myelopathy.org, the first global scientific and clinical charity dedicated to positively transforming patient outcomes in Degenerative Cervical Myelopathy (DCM), welcomes you to RECODE-DCM. This initiative started as a partnership with AO Spine, to develop a ‘research…
Myelopathy.org is receiving entries for its inaugural research award for best piece of research aligned with a RECODE-DCM Top 10 Research Priority: Raising Awareness of Degenerative Cervical Myelopathy (DCM) Natural History Diagnostic Criteria Assessment and Monitoring Biological Basis Peri-Operative Rehabilitation Novel…
Quarterly Newsletter, June 2022 AO Spine RECODE-DCM aims to accelerate research to improve outcomes in DCM. By bringing those who live with DCM together with those who treat it, our international multi-disciplinary collaboration is closing knowledge gaps. AO Spine RECODE-DCM…
Hi everyone, it’s Liz here again, with the latest installment from the AO Spine RECODE-DCM project! It has been an exciting past few weeks. The third and final consensus meeting took place on 1 June 2022 at the Global Spine…
Hi, Liz here! I’m a science communicator with a background in physiology and neurobiology. I first met the charity’s founders Dr Mark Kotter, Dr Benjamin Davies, and Iwan Sadler back in 2016 while partnering with Cambridge TV to make the…